LIGHT (protein)
Top View
- CD137+ T-Cells: Protagonists of the Immunotherapy Revolution
- BAFF and APRIL Expression in B Cells in Vitro and in Vivo
- Fas Ligand, Death Gene
- BD Horizon™ BV786 Mouse Anti-Human CD27 Antibody (Cat
- Monoclonal Anti-Fas Ligand (F2928)
- Thrombopoietin Receptor Agonist Therapy in Primary Immune
- The Thrombopoietin Receptor: Structural Basis of Traffic and Activation by Ligand, Mutations, Agonists, and Mutated Calreticulin
- B-Cell Maturation Antigen (BCMA) As a Target for New Drug Development in Relapsed And/Or Refractory Multiple Myeloma
- The Activation of BAFF/APRIL System in Spleen and Lymph Nodes
- Anti B-Cell Maturation Antigen CAR T-Cell and Antibody Drug Conjugate Therapy for Heavily Pre-Treated Relapsed and Refractory Multiple Myeloma
- Controversy: Blocking Fas Ligand Expression Suppresses Tumor Immune Evasion of Colon Cancer in Vivo
- (OX40) Proliferation in the Absence of CD134 Robust B Cell Immunity But
- Inhibition of Histone Deacetylase Activity Enhances Fas Receptor-Mediated Apoptosis in Leukemic Lymphoblasts
- An Anti-CD30 Chimeric Receptor That Mediates CD3-£-Independent T-Cell Activation Against Hodgkin's Lymphoma Cells in the Presence of Soluble CD301
- Mediated Via the Fas/Fas-Ligand System Ultraviolet Light-Induced
- An Oral, Nonpeptide Thrombopoietin Receptor Agonist
- B Cell Development the Stages of B Cell Development Ordered Gene Rearrangements a Model for Allelic Exclusion the Role of the Pr
- Anti-Human CD134 (OX40) APC Catalog Number :16411-80 RUO: for Research Use Only